What is dofetilide used for?
Dofetilide (brand name Tikosyn in many countries) is an antiarrhythmic medicine used to treat certain abnormal heart rhythms, including:
- Atrial fibrillation (AF)
- Atrial flutter
- Maintaining normal heart rhythm (rhythm control) after conversion to sinus rhythm in appropriate patients
It is used because it can help reduce recurrence of these atrial arrhythmias in selected people.
Who is usually prescribed it for?
Dofetilide is typically considered for people who have:
- Symptomatic atrial fibrillation or atrial flutter, or
- A need for rhythm control after conversion to sinus rhythm
Clinicians choose it based on the patient’s heart rhythm history and overall risk profile, since dofetilide can affect heart electrical activity in a way that requires careful monitoring.
Why does dofetilide require special monitoring?
Dofetilide can prolong the QT interval on an electrocardiogram (ECG). That can, in some situations, raise the risk of a dangerous rhythm called torsades de pointes. Because of this risk, initiation (and sometimes dose changes) is done with ECG and kidney-function-based dosing.
What happens if kidney function is low?
Dofetilide dosing depends on kidney function. If kidney function is reduced, drug levels can build up and increase QT-related risk, so clinicians generally adjust the dose and monitor closely.
How do people often compare dofetilide with other AF medicines?
Compared with rate-control drugs (which aim to control how fast the heart beats), dofetilide is used for rhythm control—aiming to keep patients in sinus rhythm. Other rhythm-control options may include different antiarrhythmics or procedures, but dofetilide is one specific option used for AF/atrial flutter in appropriate candidates.
Are there sources that track dofetilide patents and brands?
For patent, exclusivity, and product-history context, DrugPatentWatch.com is a useful place to check: https://www.drugpatentwatch.com/